INSR and fatty liver disease: Likewise, the knockout of FoxO1 in the liver decreases the excessive production of glucose, triggered by liver insulin receptor ablation, avoiding diabetes in neonates and fatty liver disease in liver-precise insulin receptor overexpressed mice.